Collaboration will evaluate Scenic's first-in-class PLA2G15 inhibitor program in Parkinson's diseaseLeveraging MJFF’s LITE consortium and world-class LRRK2 biology and biomarker infrastructure to test ...

Proof-of-concept SHEPHERD study will assess SUL-238's effects on mitochondrial function in patients with Parkinson's disease.

This guide will cover the basics of installing the Glow JavaScript library, and a few simple examples of using Glow to get you started. We are assuming you have at least a working knowledge of ...